ATAI Life Total Liabilities History

Key Indicators . Total Liab . Stocks . USA . 
Stock . ATAI Life Sciences
ATAI Stock  USD 4.16  0.04  0.97%   
Total Liabilities stood at 88.5 M as of December 31, 2025. This metric is the total amount of all liabilities that ATAI Life Sciences has, including both short-term and long-term liabilities. Over the last 16 observed reporting periods, Total Liabilities has trended higher with moderate statistical consistency (R² 0.70). Full Reported Financial Data
 
Total Liabilities  
 First Reported
2020-12-31
 Previous Quarter
79.9 M
 Current Value
88.5 M
 Quarterly Volatility
17.6 M
Macro event markers
 
Covid
 
Interest Hikes

Latest ATAI Life Total Liabilities Growth Pattern

Total Liabilities10 Years Trend
Moderate Growth
   Total Liab   
       Timeline  

Total Liabilities Trend Statistics

With a CV of 136.1% across 7 observations, ATAI Life's Total Liabilities exhibits wide dispersion driven primarily by directional growth rather than instability. The R-squared of 0.70 indicates a strong linear fit indicating consistent directional movement.
Arithmetic Mean 22,407,174
Geometric Mean 7,816,752
Coefficient Of Variation 136.12
Mean Deviation 24,345,754
Median 2,336,000
Standard Deviation 30,500,111
Sample Variance930.3T
Range90.6M
R-Value 0.84
Mean Square Error298.7T
R-Squared 0.70
Significance 0.000029
Slope 5,049,582
Total Sum of Squares14884.1T

ATAI Life Total Liabilities History

ATAI Life's Total Liabilities record extends from 2020 to 2026, covering 7 observations from 16.2 M to 93 M.
202693 M
202588.5 M
202442.8 M
202349.2 M
202239.7 M
202128.2 M
202016.2 M

Correlation of Total Liabilities With Other Accounts

The following correlation matrix compares ATAI Life's Total Liabilities against related line items. High absolute values reflect strong historical co-movement, not a causal relationship.
Click cells to compare fundamentals

Related Fundamentals

Last ReportedEnd Of Year Estimate
Total Current Liabilities23.5 M19.4 M
Liabilities And Stockholders Equity310.5 M260.3 M
Non Current Liabilities Total65.1 M68.3 M
Non Current Liabilities Other1.1 M1 M
Change To Liabilities-1.6 M-1.6 M

Methodology, Assumptions & Data Sources

The series below tracks ATAI Life's Total Liabilities across available reporting periods. The regression slope and R-squared together indicate whether the directional trend is persistent or episodic. For ATAI Life in the Biotechnology sector, Total Liabilities captures the scale of obligations used to fund operations and growth.

ATAI Life Sciences metrics are compiled from periodic company reporting and market reference feeds and normalized before display. Reference data and historical patterns are presented and do not constitute an investment recommendation or advice.

Editorial review and methodology oversight provided by: Ellen Johnson, Member of Macroaxis Editorial Board
Tools
Analysis
Directory
Company
2026 Macroaxis LLC Made with in San Francisco
Privacy Terms Widgets Feedback
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and conditions page.